Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. K. Robison
Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Role of Thrombin and Thromboxane A2 in Reocclusion Following Coronary Thrombolysis With Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator
Surgery for Cerebral Stroke
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).
The Japanese Journal of Pharmacology
The Tissue-Type Plasminogen Activator Story
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator During Early Postpartum Period: A Review of the Literature
Acta Obstetricia et Gynecologica Scandinavica
Medicine
Gynecology
Obstetrics
Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.
Journal of Pharmacobio-Dynamics